$HEPA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Hepion Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Hepion Pharmaceuticals, Inc.. Get notifications about new insider transactions in Hepion Pharmaceuticals, Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 20 2021 | HEPA | Hepion Pharmaceuti ... | JACOB GARY S | Director | Option Exercise | A | 1.70 | 250,000 | 425,000 | 342,785 | |
Feb 18 2021 | CTRV | Hepion Pharmaceuti ... | Wijngaard Peter | Director | Buy | P | 2.20 | 10,000 | 22,000 | 30,000 | 20 K to 30 K (+50.00 %) |
Feb 18 2021 | CTRV | Hepion Pharmaceuti ... | Foster Robert T | CEO and Director | Buy | P | 2.00 | 20,000 | 40,000 | 45,259 | 25.3 K to 45.3 K (+79.18 %) |
Dec 21 2020 | CTRV | Hepion Pharmaceuti ... | Wijngaard Peter | Director | Buy | P | 1.91 | 20,000 | 38,200 | 20,000 | 0 to 20 K |
Dec 08 2020 | CTRV | Hepion Pharmaceuti ... | Foster Robert T | CEO and Director | Buy | P | 1.58 | 25,000 | 39,418 | 25,259 | 259 to 25.3 K (+9,652.51 %) |
Nov 30 2020 | CTRV | Hepion Pharmaceuti ... | Cavan John T | Chief Financial Off ... | Buy | P | 1.62 | 4,500 | 7,290 | 4,800 | 300 to 4.8 K (+1,500.00 %) |
Aug 21 2020 | CTRV | Hepion Pharmaceuti ... | Foster Robert T | CEO,CSO and Directo ... | Option Exercise | A | 3.72 | 212,000 | 788,640 | 601,879 | |
Aug 21 2020 | CTRV | Hepion Pharmaceuti ... | Lippa Arnold | Director | Option Exercise | A | 3.72 | 30,000 | 111,600 | 91,110 | |
Aug 21 2020 | CTRV | Hepion Pharmaceuti ... | Block Timothy M. | Director | Option Exercise | A | 3.72 | 30,000 | 111,600 | 91,276 | |
Aug 21 2020 | CTRV | Hepion Pharmaceuti ... | ADAMS THOMAS PHD | Director | Option Exercise | A | 3.72 | 30,000 | 111,600 | 91,050 | |
Aug 21 2020 | CTRV | Hepion Pharmaceuti ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 3.72 | 30,000 | 111,600 | 91,332 | |
Aug 21 2020 | CTRV | Hepion Pharmaceuti ... | JACOB GARY S | Director | Option Exercise | A | 3.72 | 30,000 | 111,600 | 92,785 | |
Aug 21 2020 | CTRV | Hepion Pharmaceuti ... | Wijngaard Peter | Director | Option Exercise | A | 3.72 | 30,000 | 111,600 | 60,000 | |
Aug 21 2020 | CTRV | Hepion Pharmaceuti ... | Cavan John T | Chief Financial Off ... | Option Exercise | A | 3.72 | 160,000 | 595,200 | 381,060 | |
Jun 25 2020 | CTRV | Hepion Pharmaceuti ... | Wijngaard Peter | Director | Option Exercise | A | 2.73 | 30,000 | 81,900 | 30,000 | |
Apr 07 2020 | CTRV | Hepion Pharmaceuti ... | ADAMS THOMAS PHD | Director | Option Exercise | A | 1.63 | 60,000 | 97,800 | 61,051 | |
Apr 07 2020 | CTRV | Hepion Pharmaceuti ... | Block Timothy M. | Director | Option Exercise | A | 1.63 | 60,000 | 97,800 | 61,220 | |
Apr 07 2020 | CTRV | Hepion Pharmaceuti ... | Lippa Arnold | Director | Option Exercise | A | 1.63 | 60,000 | 97,800 | 61,109 | |
Apr 07 2020 | CTRV | Hepion Pharmaceuti ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 1.63 | 60,000 | 97,800 | 61,275 | |
Apr 07 2020 | CTRV | Hepion Pharmaceuti ... | Foster Robert T | CEO and CSO | Option Exercise | A | 1.63 | 380,000 | 619,400 | 389,879 | |
Apr 07 2020 | CTRV | Hepion Pharmaceuti ... | JACOB GARY S | Director | Option Exercise | A | 1.63 | 60,000 | 97,800 | 62,729 | |
Apr 07 2020 | CTRV | Hepion Pharmaceuti ... | Cavan John T | Chief Financial Off ... | Option Exercise | A | 1.63 | 215,000 | 350,450 | 221,059 | |
Jul 25 2019 | CTRV | Hepion Pharmaceuti ... | Cavan John T | Chief Financial Off ... | Option Exercise | A | 3.24 | 5,820 | 18,857 | 6,059 | |
Jul 25 2019 | CTRV | Hepion Pharmaceuti ... | JACOB GARY S | Director | Option Exercise | A | 3.24 | 970 | 3,143 | 2,729 | |
Jul 25 2019 | CTRV | Hepion Pharmaceuti ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 3.24 | 970 | 3,143 | 1,275 | |
Jul 25 2019 | CTRV | Hepion Pharmaceuti ... | Block Timothy M. | Director | Option Exercise | A | 3.24 | 970 | 3,143 | 1,220 | |
Jul 25 2019 | CTRV | Hepion Pharmaceuti ... | ADAMS THOMAS PHD | Director | Option Exercise | A | 3.24 | 970 | 3,143 | 1,051 | |
Jul 25 2019 | CTRV | Hepion Pharmaceuti ... | Foster Robert T | CEO and CSO | Option Exercise | A | 3.24 | 9,700 | 31,428 | 9,879 | |
Jul 25 2019 | CTRV | Hepion Pharmaceuti ... | Lippa Arnold | Director | Option Exercise | A | 3.24 | 970 | 3,143 | 1,109 | |
Jul 03 2018 | CTRV | ContraVir Pharmace ... | JACOB GARY S | Director | Option Exercise | P | 1.55 | 8,625 | 13,369 | 8,625 | |
Jul 03 2018 | CTRV | ContraVir Pharmace ... | JACOB GARY S | Director | Option Exercise | P | 1.55 | 15 | 23 | 15 | |
Jul 03 2018 | CTRV | ContraVir Pharmace ... | Cavan John T | CFO | Option Exercise | P | 1.55 | 8,625 | 13,369 | 8,625 | |
Jul 03 2018 | CTRV | ContraVir Pharmace ... | Cavan John T | CFO | Option Exercise | P | 1.55 | 15 | 23 | 15 | |
Jul 03 2018 | CTRV | ContraVir Pharmace ... | Lippa Arnold | Director | Option Exercise | P | 1.55 | 8,625 | 13,369 | 8,625 | |
Jul 03 2018 | CTRV | ContraVir Pharmace ... | Lippa Arnold | Director | Option Exercise | P | 1.55 | 15 | 23 | 15 | |
Jul 03 2018 | CTRV | ContraVir Pharmace ... | BRANCACCIO JOHN P | Director | Option Exercise | P | 1.55 | 1,725 | 2,674 | 1,725 | |
Jul 03 2018 | CTRV | ContraVir Pharmace ... | BRANCACCIO JOHN P | Director | Option Exercise | P | 1.55 | 3 | 5 | 3 | |
Jan 05 2018 | CTRV | ContraVir Pharmace ... | Cavan John T | CFO | Grant | A | 0.00 | 101,221 | 0 | 167,947 | 66.7 K to 167.9 K (+151.70 %) |
Jan 05 2018 | CTRV | ContraVir Pharmace ... | SAPIRSTEIN JAMES | Chief Executive Off ... | Grant | A | 0.00 | 322,092 | 0 | 492,819 | 170.7 K to 492.8 K (+188.66 %) |
Jan 05 2018 | CTRV | ContraVir Pharmace ... | Foster Robert T | Chief Scientific Of ... | Grant | A | 0.00 | 100,654 | 0 | 144,736 | 44.1 K to 144.7 K (+228.33 %) |
Jul 21 2017 | CTRV | ContraVir Pharmace ... | Cavan John T | Chief Financial Off ... | Option Exercise | A | 0.58 | 15,000 | 8,700 | 133,688 | |
Jul 07 2017 | CTRV | ContraVir Pharmace ... | Cavan John T | CFO | Grant | A | 0.00 | 46,726 | 0 | 66,726 | 20 K to 66.7 K (+233.63 %) |
Jul 07 2017 | CTRV | ContraVir Pharmace ... | SAPIRSTEIN JAMES | Chief Executive Off ... | Grant | A | 0.00 | 141,061 | 0 | 170,727 | 29.7 K to 170.7 K (+475.50 %) |
Jul 07 2017 | CTRV | ContraVir Pharmace ... | Sullivan-Bolyai John Z | Chief Medical Offic ... | Grant | A | 0.00 | 58,681 | 0 | 58,681 | 0 to 58.7 K |
Jul 07 2017 | CTRV | ContraVir Pharmace ... | Foster Robert T | Chief Scientific Of ... | Grant | A | 0.00 | 44,082 | 0 | 44,082 | 0 to 44.1 K |
Jun 22 2017 | CTRV | ContraVir Pharmace ... | Cavan John T | CFO | Buy | P | 0.65 | 20,000 | 13,000 | 20,000 | 0 to 20 K |
Apr 11 2017 | CTRV | ContraVir Pharmace ... | HOWSON TAMAR D | Director | Option Exercise | A | 1.60 | 35,000 | 56,000 | 80,000 | |
Mar 07 2017 | CTRV | ContraVir Pharmace ... | SAPIRSTEIN JAMES | Chief Executive Off ... | Option Exercise | A | 1.48 | 313,898 | 464,569 | 2,761,129 | |
Mar 07 2017 | CTRV | ContraVir Pharmace ... | SAPIRSTEIN JAMES | Chief Executive Off ... | Option Exercise | A | 1.43 | 313,898 | 448,874 | 2,447,231 | |
Oct 31 2016 | CTRV | ContraVir Pharmace ... | SAPIRSTEIN JAMES | Chief Executive Off ... | Option Exercise | M | 1.50 | 16,666 | 24,999 | 2,133,334 | |
Oct 31 2016 | CTRV | ContraVir Pharmace ... | SAPIRSTEIN JAMES | Chief Executive Off ... | Buy | M | 1.50 | 16,666 | 24,999 | 29,666 | 13 K to 29.7 K (+128.20 %) |
Aug 29 2016 | CTRV | ContraVir Pharmace ... | Sullivan-Bolyai John Z | Chief Medical Offic ... | Option Exercise | A | 1.10 | 135,790 | 149,369 | 290,790 | |
Aug 29 2016 | CTRV | ContraVir Pharmace ... | Cavan John T | Chief Financial Off ... | Option Exercise | A | 1.10 | 18,688 | 20,557 | 118,688 | |
Jul 20 2016 | CTRV | ContraVir Pharmace ... | Lippa Arnold | Director | Option Exercise | A | 1.04 | 32,500 | 33,800 | 77,500 | |
Jul 20 2016 | CTRV | ContraVir Pharmace ... | Block Timothy M. | Director | Option Exercise | A | 1.04 | 65,000 | 67,600 | 169,688 | |
Jul 20 2016 | CTRV | ContraVir Pharmace ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 1.04 | 65,000 | 67,600 | 200,656 | |
Jul 20 2016 | CTRV | ContraVir Pharmace ... | JACOB GARY S | Director | Option Exercise | A | 1.04 | 65,000 | 67,600 | 1,015,000 | |
Jun 14 2016 | CTRV | ContraVir Pharmace ... | Sullivan-Bolyai John Z | Chief Medical Offic ... | Option Exercise | A | 0.99 | 20,000 | 19,800 | 155,000 | |
Jun 14 2016 | CTRV | ContraVir Pharmace ... | SAPIRSTEIN JAMES | Chief Executive Off ... | Option Exercise | A | 0.99 | 500,000 | 495,000 | 2,150,000 | |
Feb 18 2016 | CTRV | ContraVir Pharmace ... | SAPIRSTEIN JAMES | Chief Executive Off ... | Buy | P | 1.00 | 10,000 | 10,000 | 13,000 | 3 K to 13 K (+333.33 %) |
Dec 01 2015 | CTRV | ContraVir Pharmace ... | SAPIRSTEIN JAMES | Chief Executive Off ... | Buy | P | 2.15 | 500 | 1,075 | 3,000 | 2.5 K to 3 K (+20.00 %) |
Nov 24 2015 | CTRV | ContraVir Pharmace ... | SAPIRSTEIN JAMES | Chief Executive Off ... | Buy | P | 1.64 | 2,500 | 4,100 | 2,500 | 0 to 2.5 K |
Jun 08 2015 | CTRV | ContraVir Pharmace ... | Hornung William Karl | Chief Financial Off ... | Option Exercise | A | 3.60 | 15,000 | 54,000 | 165,000 | |
Jun 08 2015 | CTRV | ContraVir Pharmace ... | SAPIRSTEIN JAMES | Chief Executive Off ... | Option Exercise | A | 3.60 | 150,000 | 540,000 | 1,650,000 | |
Dec 04 2014 | CTRV | ContraVir Pharmace ... | SAPIRSTEIN JAMES | Chief Executive Off ... | Option Exercise | A | 1.50 | 500,000 | 750,000 | 1,500,000 | |
Dec 04 2014 | CTRV | ContraVir Pharmace ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 1.50 | 38,759 | 58,139 | 135,656 | |
Dec 04 2014 | CTRV | ContraVir Pharmace ... | McGuigan Christopher | Director | Option Exercise | A | 1.50 | 118,638 | 177,957 | 415,234 | |
Dec 04 2014 | CTRV | ContraVir Pharmace ... | Block Timothy M. | Director | Option Exercise | A | 1.50 | 29,911 | 44,867 | 104,688 | |
Dec 04 2014 | CTRV | ContraVir Pharmace ... | JACOB GARY S | Director | Option Exercise | A | 1.50 | 420,000 | 630,000 | 950,000 | |
Dec 04 2014 | CTRV | ContraVir Pharmace ... | Hornung William Karl | Chief Financial Off ... | Option Exercise | A | 1.50 | 50,000 | 75,000 | 150,000 | |
Apr 04 2014 | CTRV | ContraVir Pharmace ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 2.35 | 15,000 | 35,250 | 96,897 | |
Apr 04 2014 | CTRV | ContraVir Pharmace ... | Block Timothy M. | Director | Option Exercise | A | 2.35 | 15,000 | 35,250 | 74,777 | |
Apr 04 2014 | CTRV | ContraVir Pharmace ... | Denoyer Bernard | Chief Financial Off ... | Option Exercise | A | 2.35 | 20,000 | 47,000 | 40,000 | |
Mar 20 2014 | CTRV | ContraVir Pharmace ... | JACOB GARY S | Director | Option Exercise | A | 2.31 | 300,000 | 693,000 | 530,000 | |
Mar 14 2014 | CTRV | ContraVir Pharmace ... | McGuigan Christopher | Director | Option Exercise | A | 2.37 | 16,596 | 39,333 | 296,596 | |
Mar 14 2014 | CTRV | ContraVir Pharmace ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 2.37 | 21,897 | 51,896 | 81,897 | |
Mar 14 2014 | CTRV | ContraVir Pharmace ... | Block Timothy M. | Director | Option Exercise | A | 2.37 | 19,777 | 46,871 | 59,777 | |
Mar 07 2014 | CTRV | ContraVir Pharmace ... | BRANCACCIO JOHN P | Director | Buy | P | 1.49 | 4,393 | 6,546 | 6,408 | 2 K to 6.4 K (+218.01 %) |
Feb 20 2014 | CTRV | ContraVir Pharmace ... | Denoyer Bernard | Chief Financial Off ... | Buy | J | 0.00 | 1,030 | 0 | 1,030 | 0 to 1 K |
Feb 20 2014 | CTRV | ContraVir Pharmace ... | JACOB GARY S | CEO and President | Buy | J | 0.00 | 32,935 | 0 | 32,935 | 0 to 32.9 K |
Feb 20 2014 | CTRV | ContraVir Pharmace ... | BRANCACCIO JOHN P | Director | Buy | J | 0.00 | 2,015 | 0 | 2,015 | 0 to 2 K |
Feb 20 2014 | CTRV | ContraVir Pharmace ... | SYNERGY PHARMACEUTICALS, INC. | 10% Owner | Sell | J | 0.00 | 9,000,000 | 0 | 0 | 9 M to 0 (-100.00 %) |
Jan 28 2014 | CTRV | ContraVir Pharmace ... | BRANCACCIO JOHN P | Director | Option Exercise | A | 0.37 | 30,000 | 11,100 | 60,000 | |
Jan 28 2014 | CTRV | ContraVir Pharmace ... | Denoyer Bernard | Director | Option Exercise | A | 0.37 | 10,000 | 3,700 | 20,000 | |
Jan 28 2014 | CTRV | ContraVir Pharmace ... | Block Timothy M. | Director | Option Exercise | A | 0.37 | 10,000 | 3,700 | 40,000 | |
Jan 28 2014 | CTRV | ContraVir Pharmace ... | JACOB GARY S | CEO and President | Option Exercise | A | 0.37 | 200,000 | 74,000 | 230,000 | |
Jan 28 2014 | CTRV | ContraVir Pharmace ... | McGuigan Christopher | Director | Option Exercise | A | 0.37 | 250,000 | 92,500 | 280,000 | |
Nov 26 2013 | CTRV | ContraVir Pharmace ... | Denoyer Bernard | CFO and Secretary | Option Exercise | A | 0.11 | 10,000 | 1,100 | 10,000 |
Page: 1